Premium Only Content
This video is only available to Rumble Premium subscribers. Subscribe to
enjoy exclusive content and ad-free viewing.

Inside Soligenix: Innovations in Rare Disease Therapies
1 year ago
2
Soligenix
biopharmaceutical
rare disease treatments
Specialized BioTherapeutics
HyBryte™ for CTCL
Phase 3 study
HyBryte™ marketing approval
synthetic hypericin (SGX302) for psoriasis
oral beclomethasone 17
21-dipropionate (BDP) for GI disorders
dusquetide (SGX942) for inflammatory diseases
Soligenix, a leading biopharmaceutical company, has a promising pipeline of breakthrough treatments, including HyBryte™ for cutaneous T-cell lymphoma. This innovative therapy, with positive Phase 3 results published in JAMA Dermatology, targets a global market worth $250 million, addressing a critical medical need. Soligenix is on the cusp of major success with the potential for over $2 billion in annual sales. Learn more at https://www.redchip.com/stocks/SNGX/.
Loading comments...
-
LIVE
OneRandomDolly
1 hour ago[GB]Long Stream?!?! ✨ Turtle Beach Partner !TB
132 watching -
20:33
Sideserf Cake Studio
1 day ago $2.94 earnedI Built A Bikini Bottom Fish Tank CAKE!
16.2K11 -
LIVE
Atarithepaladin
13 hours agoPaladin Playthrough Ep 17
106 watching -
10:35
Warren Smith - Secret Scholar Society
1 day agoExposing the Illusion of Gary's Economics
52K11 -
13:14
Michael Button
1 day ago $3.16 earnedThere’s a Giant Hole in Human History
18.3K22 -
9:23
Russell Brand
21 hours agoThe TRUTH Behind Stephen Colbert's Downfall
59.4K78 -
17:47
T-SPLY
1 day agoDems Fume: L.A Protesters Clash With Federal Agents And National Guard...Again!
14.6K14 -
LIVE
Lofi Girl
2 years agolofi hip hop radio 📚 - beats to relax/study to
370 watching -
22:50
marcushouse
1 day ago $1.19 earnedStarship Tech Update Reveal, and Fire Time Already!? 🔥
12.9K5 -
53:17
The Car Guy Online
22 hours ago $1.59 earnedNextGen Engineer Reveals How GM Is Quietly Fixing 10-Speed Problems.
12.7K1